Moberg Pharma AB is a pharmaceutical company. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. It has a single operating segment, the development, and commercialization of medical products. It derives most of its revenues from the United States of America.
